Search - tctmd.com

Displaying 981 - 1000 of 1179

Sort: Relevancy | Date

Presentation

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Presenter: R. Piccolo

June 04, 2012

Presentation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Presenter: T. Tada

June 01, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Industry News

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

May 23, 2012

News Conference News EuroPCR 2012

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Jason Kahn

May 17, 2012

News Conference News EuroPCR 2012

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

Jason Kahn

May 16, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Industry News

New Data From Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

May 11, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Daily News

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 09, 2012

News Features

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 07, 2012

News Daily News

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

May 04, 2012

News Daily News

High Prasugrel Reloading Dose Best for Suppressing Platelet Reactivity Prior to PCI

Jason Kahn

May 01, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

April 19, 2012

Advertisement

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

Watchman Works Just as Well Without Warfarin-Protected Transition

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

New Data From Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

High Prasugrel Reloading Dose Best for Suppressing Platelet Reactivity Prior to PCI

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content